Provided by Tiger Trade Technology Pte. Ltd.

Adagene

2.97
-0.3000-9.17%
Volume:626.15K
Turnover:1.89M
Market Cap:199.42M
PE:-7.87
High:3.39
Open:3.39
Low:2.93
Close:3.27
52wk High:4.85
52wk Low:1.30
Shares:67.14M
Float Shares:42.20M
Volume Ratio:2.85
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3773
EPS(LYR):-0.3750
ROE:-28.50%
ROA:-13.95%
PB:2.23
PE(LYR):-7.92

Loading ...

Adagene Price Target Maintained with a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 14

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

TIPRANKS
·
Sep 11

Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8

TIPRANKS
·
Sep 10

Adagene, Third Arc Bio Expand SAFEbody Masked CD3 T-Cell Engager Collaboration with First Lead Pick

Reuters
·
Sep 10

Adagene Initiated at Buy by Chardan Capital

Dow Jones
·
Sep 10

Chardan Initiates Adagene at Buy With $9 Price Target

MT Newswires Live
·
Sep 10

Adagene initiated with a Buy at Chardan

TIPRANKS
·
Sep 10

Adagene Receives Milestone Payment From Exelixis

MT Newswires Live
·
Sep 09

Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration

TIPRANKS
·
Sep 09

Adagene Receives USD 2 Million Exelixis Milestone Payment for SAFEbody ADC Program

Reuters
·
Sep 09

Adagene Hits Preclinical Milestone for Exelixis-Partnered XB404 SAFEbody ADC, Triggers $2 Million Payment

Reuters
·
Sep 09

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

GlobeNewswire
·
Sep 09

Adagene Posts Investor Presentation on Masked Anti-CTLA-4 Program Adg126

Reuters
·
Sep 04

Adagene Management Attends Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Aug 20

Adagene to Participate in Three Upcoming Investor Conferences

GlobeNewswire
·
Aug 20

Adagene Director Cuong Do Reports Purchase of ADS Worth $7,500

Reuters
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)

TIPRANKS
·
Aug 17

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)

TIPRANKS
·
Aug 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Adagene FY26 H1 Net Loss Widens to US$ 16.4 Million; Revenue Turns to US$ 1.6 Million

Reuters
·
Aug 12